Guides.

What the published studies say about each compound, written for researchers comparing compounds.

Peptides4 minSelank UK: The Selank Peptide Guide (2026)Selank for UK buyers: the tuftsin analogue, its Russian licence for anxiety, the GABA and immune studies, storage... Peptides4 minSemax UK: Semax Peptide and Nasal Spray Explained (2026)Semax for UK buyers: the ACTH 4-10 analogue, its Russian licence for stroke, the BDNF and attention studies,... Peptides3 min5-Amino-1MQ UK: what the research says in 20265-Amino-1MQ for UK buyers: the NNMT inhibitor, the obese mouse studies, why it is not a peptide, storage... Peptides3 minHGH Fragment 176-191 UK: what the research says in 2026HGH Fragment 176-191 (AOD9604) for UK buyers: the lipolytic fragment, the obesity trials that failed, the animal data,... Peptides5 minSermorelin UK: The Sermorelin Peptide Guide (2026)Sermorelin for UK buyers: the GHRH 1-29 fragment, its history as a licensed paediatric medicine, the adult studies,... Peptides5 minCJC-1295 and Ipamorelin UK: The Peptide Blend Guide (2026)CJC-1295 and Ipamorelin for UK buyers: how a GHRH analogue and a ghrelin mimetic differ, the human studies,... Peptides9 minNAD+ UK: What the Studies Show (2026)NAD+ for UK buyers: what the coenzyme does, the mouse ageing studies, why oral, injected and precursor forms... Peptides7 minGHK-Cu UK: What the Copper Peptide Studies Show (2026)GHK-Cu copper peptide for UK buyers: the skin and wound studies, gene expression work, cosmetic versus research grade,... Peptides7 minTB-500 UK: What the Studies Show (2026)TB-500 (thymosin beta-4 fragment) for UK buyers: actin mechanism, wound and cardiac studies, how it differs from BPC-157,... Peptides6 minBPC-157 UK: What the Studies Show (2026)BPC-157 explained for UK buyers: what the rodent tendon, gut and vessel studies found, storage, 2026 legal status... Peptides6 minSARMs vs peptides: what the research actually compares, UK 2026Two different classes of research compound that get lumped together online. How they work, what has been studied,... SARMs4 minACP-105 UK: what the research says in 2026ACP-105 is a partial androgen receptor agonist that never left the laboratory. What the preclinical work found, what...